Cyclacel
Cyclacel is a biopharmaceutical company that develops orally available small molecule drugs which target various cell cycle phases.
Business Model:
Revenue: $150k
Employees: 11-50
Industries / Tags:
Detailed Cyclacel Information
Geographic Data
Address: 200 Connell Drive
City: Berkeley Heights
State: NJ
Zip: 07922
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$15M
Raised Total:$167M
Social
Metrics
3,274,077Website Global Rank
4,681Website Monthly Traffic
Twitter Followers
Description
Cyclacel is a biopharmaceutical company that develops orally available small molecule drugs which target various cell cycle phases.
Contact Phone:
+19085177330
Contact Email:
Cyclacel went public on 4/7/2006 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/7/2006
IPO Valuation:
$118M
Ticker Symbol:
CYCC
IPO Price:
$8/share
Amount Raised:
$34M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
